Niagen Bioscience vs Nu Skin
Nu Skin reported revenue of $1.5 billion in fiscal 2025, 11.5 times Niagen Bioscience's $129 million in fiscal 2025. Niagen Bioscience's revenue grew 29.9% in its latest year, and Nu Skin's fell 14.3%. Niagen Bioscience had an operating margin of 12.6%, against 4.4% at Nu Skin.
Side by side
| Niagen Bioscience | Nu Skin | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $129M | $1.5B |
| Revenue growth | 29.9% | −14.3% |
| Revenue growth a year, last 5 years | 16.9% | −10.5% |
| Gross margin | 64.3% | 69.5% |
| Operating margin | 12.6% | 4.4% |
| Net margin | 13.4% | 10.8% |
| Free cash flow | — | $46M |
| Free cash flow margin | — | 3.1% |
| Return on capital | — | 6.5% |
| Net debt to EBITDA | −3.8x | −0.1x |
| Dividends and buybacks | $0M | $32M |
| Change in diluted share count | 9.4% | 1.3% |
| Last close | $2.06 | $4.03 |
| P/E at the last close | 17.2× | — |
| Insider trades, last 12 months | bought $45,616, sold $0 | sold $99,547 |
| Piotroski F-score | 6 of 9 | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Niagen BioscienceNu Skin
Operating margin
Percent of revenue
Niagen BioscienceNu Skin
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Niagen BioscienceNu Skin
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Niagen Bioscience and Nu Skin pages.